Position in ANIP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,745,411
+$172,999 QoQ
Shares Held
81,486
-4.7% QoQ
Ownership
0.355%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#62
of 303 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $406,344,526 across 19 Drug Manufacturers - Specialty & Generic names. ANIP ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,556,307 | $111,836,221 | |
| 2 | VTRS |
Viatris Inc
|
5,928,142 | $94,138,894 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
155,398 | $84,199,298 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
419,770 | $70,748,035 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
277,282 | $10,037,608 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
186,134 | $8,798,554 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
This page
|
81,486 | $6,745,411 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
212,814 | $5,399,091 |
All Filings in ANIP
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,745,411 | 81,486 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,572,412 | 85,467 | Shares | Sole | 2026-06-18 | |
| 2025-12-31 | $6,308,805 | 79,919 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $381,056 | 4,160 | Shares | Sole | 2025-10-15 | |
| 2024-12-31 | $100,996 | 1,827 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $33,907,343 | 568,343 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $154,933 | 2,433 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $62,977 | 911 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $41,134 | 746 | Shares | Sole | 2024-01-16 | |
| No filing history on record for this holder in this stock. | ||||||